LCO 1 of 4
General Assembly Substitute Bill No. 6915
January Session, 2025
AN ACT CONCERNING THE USE OF SECOND -GENERATION
ANTICOAGULANT RODENTICIDES.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (NEW) (Effective October 1, 2025) (a) No person shall engage 1
in the use in this state of any second-generation anticoagulant 2
rodenticide. For purposes of this section, "second-generation 3
anticoagulant rodenticide" means any pesticide product containing any 4
one of the following active ingredients: (1) Brodifacoum; (2) 5
bromadiolone; (3) difenacoum; or (4) difethialone. 6
(b) The provisions of subsection (a) of this section shall not apply to: 7
(1) The use of second-generation anticoagulant rodenticides by any 8
state employee who uses second-generation anticoagulant rodenticides 9
for public health activities in accordance with any provision of the 10
Public Health Code and in furtherance of such employee's duties; 11
(2) The use of second-generation anticoagulant rodenticides when 12
used by any state employee for the purposes of protecting water supply 13
infrastructure and facilities in a manner that is consistent with all 14
otherwise applicable federal and state laws and regulations and in 15
furtherance of such employee's duties; 16
(3) The use of second-generation anticoagulant rodenticides by a 17 Substitute Bill No. 6915
LCO 2 of 4
director of health to control mosquito or vector breeding areas in order 18
to protect the public health; 19
(4) The use of any second-generation anticoagulant rodenticides for 20
the eradication of nonnative invasive species inhabiting or found to be 21
present on offshore islands in a manner that is consistent with all 22
otherwise applicable federal and state laws and regulations; 23
(5) The use of any second-generation anticoagulant rodenticide to 24
control an actual or potential rodent infestation associated with a public 25
health need, as determined by a supporting declaration from the 26
Commissioner of Public Health or a director of health. For purposes of 27
this section, "public health need" means an urgent, nonroutine situation 28
posing a significant risk to human health in which it is documented that 29
other rodent control alternatives, including nonchemical alternatives, 30
are inadequate to control the rodent infestation; 31
(6) The use of second-generation rodenticides in any of the following 32
locations: (A) A medical waste generator; or (B) any facility registered 33
annually and subject to inspection under Section 510 of the federal Food, 34
Drug and Cosmetic Act, 21 USC 360 et seq., and that is compliant with 35
the federal Insecticide, Fungicide and Rodenticide Act, 7 USC 135 et 36
seq.; or 37
(7) The use of second-generation anticoagulant rodenticides for 38
agricultural activities. For purposes of this subdivision, "agricultural 39
activities" includes activities conducted in any of the following 40
locations: 41
(A) A warehouse used to store foods for human or animal 42
consumption; 43
(B) An agricultural production site, including, but not limited to, a 44
slaughterhouse or cannery; 45
(C) A factory, brewery or winery; 46
(D) An agricultural production site housing water storage and 47 Substitute Bill No. 6915
LCO 3 of 4
conveyance facilities; or 48
(E) An agricultural production site housing rights-of-way and other 49
transportation infrastructure. 50
(c) The Commissioner of Energy and Environmental Protection may 51
adopt regulations, in accordance with the provisions of chapter 54 of the 52
general statutes, to ensure that the continued use of second-generation 53
anticoagulant rodenticides, in accordance with the provisions of section 54
22a-50 of the general statutes is not reasonably expected to result in 55
significant adverse effects to nontarget wildlife. Any such regulations 56
shall include, but are not limited to, provisions for the use of such 57
rodenticides if the eradication of invasive rodent populations is 58
necessary for the protection of threatened or endangered species or the 59
habitats of such species. 60
(d) Not later than January 1, 2027, the Commissioner of Energy and 61
Environmental Protection shall submit a report, in accordance with the 62
provisions of section 11-4a of the general statutes, to the joint standing 63
committee of the General Assembly having cognizance of matters 64
relating to the environment on the potential implications of the 65
application of existing statutory and regulatory restrictions and 66
licensing requirements for the use of second-generation anticoagulant 67
rodenticides. Such report shall include, but is not limited to, an analysis 68
of the consistency of applying such restrictions and requirements with 69
federal law and any potential effects, including, but not limited to, 70
improved raptor health and expenses and delays that such changes may 71
have on public health and agriculture in the state and requisite 72
administrative resources for overseeing such restrictions. 73
(e) Any person who violates the provisions of subsection (a) of this 74
section shall be subject to a civil penalty of not more than five thousand 75
dollars by the Commissioner of Energy and Environmental Protection 76
for each such violation. 77 Substitute Bill No. 6915
LCO 4 of 4
This act shall take effect as follows and shall amend the following
sections:
Section 1 October 1, 2025 New section
ENV Joint Favorable Subst.